| Market Cap | 5.55B | P/E | 28.99 | EPS this Y | -54.20% | Ern Qtrly Grth | - |
| Income | -1.32B | Forward P/E | 16.15 | EPS next Y | 58.60% | 50D Avg Chg | - |
| Sales | 2.53B | PEG | -2.93 | EPS past 5Y | -2.67% | 200D Avg Chg | -5.00% |
| Dividend | N/A | Price/Book | 1.29 | EPS next 5Y | -9.20% | 52W High Chg | -22.00% |
| Recommedations | 2.70 | Quick Ratio | 1.73 | Shares Outstanding | 171.95M | 52W Low Chg | 9.00% |
| Insider Own | 0.77% | ROA | 2.28% | Shares Float | 171.37M | Beta | 1.32 |
| Inst Own | 112.13% | ROE | -36.33% | Shares Shorted/Prior | 15.68M/11.17M | Price | 33.92 |
| Gross Margin | 54.89% | Profit Margin | -52.25% | Avg. Volume | 2,159,327 | Target Price | 17.56 |
| Oper. Margin | 1.00% | Earnings Date | Oct 30 | Volume | 4,076,661 | Change | -0.26% |
Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products. This segment also provides software packages, which include DTX Studio Implant; DTX Studio Lab; and DTX Studio Clinic, a software package offered with its imaging products. It offers its products under the Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, Ormco, Spark, Orascoptic, Damon, Insignia, AOA brands. The Equipment & Consumables segment provides dental equipment and supplies, including digital imaging systems, software, and other visualization/magnification systems; endodontic systems and related products; restorative materials, rotary burs, impression materials, bonding agents, and cements; and infection prevention products. This segment offers its products under the Dexis, DTX Studio, Kerr, Metrex, Total Care, Pentron, Optibond, Harmonize, Sonicfill, Sybron Endo, and CaviWipes to dental offices, clinics, and hospitals. Envista Holdings Corporation was incorporated in 2018 and is headquartered in Brea, California.
| B of A Securities | Buy | Aug 8, 24 |
| Evercore ISI Group | Outperform | Aug 8, 24 |
| JP Morgan | Neutral | Aug 8, 24 |
| Needham | Hold | Aug 8, 24 |
| Stifel | Buy | Jul 30, 24 |
| Piper Sandler | Neutral | Jul 30, 24 |
| Baird | Neutral | Jul 22, 24 |
| Needham | Hold | Jul 16, 24 |
| Evercore ISI Group | Outperform | Jun 25, 24 |
| Insider Trades | Relationship | Date | Transactions | Cost($) | #Shares | Value($) | #Share Own | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| Conley Eric | SVP, Orthodontics SVP, Orthodontics | Nov 16 | Buy | 22.9 | 2,185 | 50,036 | 47,376 | 11/20/23 |
| Yu Howard H | Chief Financial Offi.. Chief Financial Officer | Nov 17 | Sell | 36.55 | 657 | 24,013 | 51,106 | 11/21/22 |
| Yu Howard H | Chief Financial Offi.. Chief Financial Officer | Apr 18 | Sell | 45.73 | 5,341 | 244,244 | 52,411 | 04/20/22 |
| Aghdaei Amir | Chief Executive Offi.. Chief Executive Officer | Mar 29 | Sell | 51.63 | 10,538 | 544,077 | 364,779 | 03/31/22 |
| Aghdaei Amir | Chief Executive Offi.. Chief Executive Officer | Mar 16 | Option | 15.89 | 114,702 | 1,822,615 | 500,557 | 03/18/22 |
| Aghdaei Amir | Chief Executive Offi.. Chief Executive Officer | Mar 16 | Sell | 48.09 | 128,752 | 6,191,684 | 385,855 | 03/18/22 |
| Reis Mischa | SVP, Strategy & Bus... SVP, Strategy & Bus. Dev. | Mar 01 | Sell | 47.83 | 2,958 | 141,481 | 31,327 | 03/02/22 |
| Bludworth Curt W | Chief Human Resource.. Chief Human Resources Officer | Mar 01 | Sell | 47.83 | 4,181 | 199,977 | 46,759 | 03/02/22 |
| Yu Howard H | Chief Financial Offi.. Chief Financial Officer | Feb 25 | Sell | 47.81 | 3,598 | 172,020 | 57,752 | 03/01/22 |
| Reis Mischa | SVP, Strategy & Bus... SVP, Strategy & Bus. Dev. | Feb 25 | Sell | 47.71 | 4,278 | 204,103 | 34,285 | 03/01/22 |
| Reis Mischa | SVP, Strategy & Bus... SVP, Strategy & Bus. Dev. | Feb 24 | Option | 16.51 | 5,009 | 82,699 | 41,787 | 02/28/22 |
| Reis Mischa | SVP, Strategy & Bus... SVP, Strategy & Bus. Dev. | Feb 24 | Sell | 47.59 | 5,009 | 238,378 | 36,778 | 02/28/22 |
| Aghdaei Amir | Chief Executive Offi.. Chief Executive Officer | Dec 27 | Option | 15.89 | 29,703 | 471,981 | 442,358 | 12/29/21 |
| Aghdaei Amir | Chief Executive Offi.. Chief Executive Officer | Dec 27 | Sell | 46.76 | 58,042 | 2,714,044 | 434,724 | 12/29/21 |
| Reis Mischa | SVP, Strategy & Bus... SVP, Strategy & Bus. Dev. | Aug 27 | Sell | 42.5 | 10,016 | 425,680 | 39,043 | 08/27/21 |
| Reis Mischa | SVP, Strategy & Bus... SVP, Strategy & Bus. Dev. | Aug 27 | Option | 16.51 | 10,016 | 165,364 | 49,059 | 08/27/21 |
| Bludworth Curt W | Chief Human Resource.. Chief Human Resources Officer | Jun 15 | Option | 12.65 | 14,654 | 185,373 | 78,212 | 06/15/21 |
| Reis Mischa | SVP, Strategy & Bus... SVP, Strategy & Bus. Dev. | May 11 | Option | 12.64 | 15,519 | 196,160 | 64,678 | 05/11/21 |
| Reis Mischa | SVP, Strategy & Bus... SVP, Strategy & Bus. Dev. | May 11 | Sell | 45.94 | 25,479 | 1,170,505 | 39,199 | 05/11/21 |
| Yu Howard H | Chief Financial Offi.. Chief Financial Officer | May 11 | Option | 17.15 | 35,021 | 600,610 | 94,908 | 05/11/21 |
| Yu Howard H | Chief Financial Offi.. Chief Financial Officer | May 11 | Sell | 45.17 | 35,021 | 1,581,899 | 59,887 | 05/11/21 |
| Aghdaei Amir | Chief Executive Offi.. Chief Executive Officer | May 10 | Option | 15.27 | 70,074 | 1,070,030 | 532,380 | 05/10/21 |
| Aghdaei Amir | Chief Executive Offi.. Chief Executive Officer | May 10 | Sell | 44.97 | 87,301 | 3,925,926 | 493,484 | 05/10/21 |
| Kappler Jeffrey | Senior Vice Presiden.. Senior Vice President | Apr 09 | Option | 19.27 | 12,539 | 241,627 | 51,900 | 04/09/21 |
| Kappler Jeffrey | Senior Vice Presiden.. Senior Vice President | Apr 09 | Sell | 44.95 | 13,473 | 605,611 | 38,427 | 04/09/21 |
| Yu Howard H | Chief Financial Offi.. Chief Financial Officer | Apr 09 | Option | 17.15 | 1,702 | 29,189 | 61,589 | 04/09/21 |
| Yu Howard H | Chief Financial Offi.. Chief Financial Officer | Mar 24 | Option | 12.64 | 10,908 | 137,877 | 84,308 | 03/24/21 |
| Yu Howard H | Chief Financial Offi.. Chief Financial Officer | Mar 24 | Sell | 41.07 | 24,421 | 1,002,970 | 59,887 | 03/24/21 |